Ignoring the problem of heart failure is ‘not a sensible option’ Newsletter Article 18 February 2013 Pages: 2 - 2
New UK guidelines for the management of osteoporosis Newsletter Article 18 February 2013 Pages: 4 - 4
Caregivers willing to pay for donepezil treatment for dementia Newsletter Article 18 February 2013 Pages: 6 - 6
GnRH agonists and antagonists square up for a fight David Jack Newsletter Article 18 February 2013 Pages: 9 - 10
Rofecoxib appears promising in moderate-to-severe pain Newsletter Article 18 February 2013 Pages: 11 - 11
Linezolid shows promise against Gram-positive bacteria Newsletter Article 18 February 2013 Pages: 11 - 11
Extended anticoagulation reduces recurrence of thromboembolism Newsletter Article 18 February 2013 Pages: 12 - 12
Ebastine runs rings around runny noses Tracey Earl Newsletter Article 18 February 2013 Pages: 13 - 14
Cladribine regimen feasible in lymphoproliferative malignancies Newsletter Article 18 February 2013 Pages: 14 - 14
Combination chemotherapy shows promise in head and neck cancer Newsletter Article 18 February 2013 Pages: 15 - 15
Zafirlukast monotherapy in severe persistent asthma? Newsletter Article 18 February 2013 Pages: 18 - 18
Transdermal fentanyl feasible and well tolerated in children Newsletter Article 18 February 2013 Pages: 20 - 20
Women may be at increased risk of heart rupture after thrombolytics Newsletter Article 18 February 2013 Pages: 21 - 21
Troglitazone use rejected in UK, but reaffirmed in US Newsletter Article 18 February 2013 Pages: 21 - 21